Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Poole

Showing results (251-260 of 302) with videos related to

Pageof 31
Sort By:
Circulation|February 8, 2021
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA TrialDouglas L Packer, Jonathan P Piccini, Kristi H Monahan, et al.
Plos One|March 14, 2023
Defibrillation effectiveness and safety of the shock waveform used in a contemporary wearable cardioverter defibrillator: Results from animal and human studiesMarye J Gleva, Joseph Sullivan, Thomas C Crawford, et al.
JACC. Clinical Electrophysiology|October 3, 2021
Risk Factors for CIED Infection After Secondary Procedures: Insights From the WRAP-IT TrialKhaldoun G Tarakji, Andrew D Krahn, Jeanne E Poole, et al.
American Heart Journal|May 15, 2018
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and DesignDouglas L Packer, Daniel B Mark, Richard A Robb, et al.
JACC. Clinical Electrophysiology|August 25, 2018
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk EstimatesWayne C Levy, Anne S Hellkamp, Daniel B Mark, et al.
Circulation|January 27, 2021
Association Between Sex and Treatment Outcomes of Atrial Fibrillation Ablation Versus Drug Therapy: Results From the CABANA TrialAndrea M Russo, Emily P Zeitler, Anna Giczewska, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 25, 2015
Recommendations for the management of sickle cell disease in South AfricaN A Alli, M Patel, H D Alli, et al.
Biomedical Instrumentation & Technology|January 12, 1999
Treatment of out-of-hospital cardiac arrest with a low-energy impedance-compensating biphasic waveform automatic external defibrillator. The LIFE InvestigatorsB E Gliner, D B Jorgenson, J E Poole, et al.
Heart Rhythm|October 2, 2010
An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure TrialDavid G Strauss, Jeanne E Poole, Galen S Wagner, et al.
JAMA|March 16, 2019
Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical TrialDaniel B Mark, Kevin J Anstrom, Shubin Sheng, et al.
Pageof 31

Showing results (251-260 of 302) with videos related to

Sort By:
Pageof 31
Circulation|February 8, 2021
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA TrialDouglas L Packer, Jonathan P Piccini, Kristi H Monahan, et al.
Plos One|March 14, 2023
Defibrillation effectiveness and safety of the shock waveform used in a contemporary wearable cardioverter defibrillator: Results from animal and human studiesMarye J Gleva, Joseph Sullivan, Thomas C Crawford, et al.
JACC. Clinical Electrophysiology|October 3, 2021
Risk Factors for CIED Infection After Secondary Procedures: Insights From the WRAP-IT TrialKhaldoun G Tarakji, Andrew D Krahn, Jeanne E Poole, et al.
American Heart Journal|May 15, 2018
Catheter Ablation versus Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) Trial: Study Rationale and DesignDouglas L Packer, Daniel B Mark, Richard A Robb, et al.
JACC. Clinical Electrophysiology|August 25, 2018
Improving the Use of Primary Prevention Implantable Cardioverter-Defibrillators Therapy With Validated Patient-Centric Risk EstimatesWayne C Levy, Anne S Hellkamp, Daniel B Mark, et al.
Circulation|January 27, 2021
Association Between Sex and Treatment Outcomes of Atrial Fibrillation Ablation Versus Drug Therapy: Results From the CABANA TrialAndrea M Russo, Emily P Zeitler, Anna Giczewska, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|April 25, 2015
Recommendations for the management of sickle cell disease in South AfricaN A Alli, M Patel, H D Alli, et al.
Biomedical Instrumentation & Technology|January 12, 1999
Treatment of out-of-hospital cardiac arrest with a low-energy impedance-compensating biphasic waveform automatic external defibrillator. The LIFE InvestigatorsB E Gliner, D B Jorgenson, J E Poole, et al.
Heart Rhythm|October 2, 2010
An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure TrialDavid G Strauss, Jeanne E Poole, Galen S Wagner, et al.
JAMA|March 16, 2019
Effect of Catheter Ablation vs Medical Therapy on Quality of Life Among Patients With Atrial Fibrillation: The CABANA Randomized Clinical TrialDaniel B Mark, Kevin J Anstrom, Shubin Sheng, et al.
Pageof 31